REKAMBYS 900 mg / 3 ml, Depot-Injektionssuspension
7680677420023
CH-67742
Injektionssuspension
Associated product:
REKAMBYS Depot susp inj 900 mg/3ml flac 3 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionssuspension
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rilpivirinum
|
900.0 MG | Substance | Wirkstoff (Principe actif) |
|
poloxamerum 338
|
- | Substance | HNIDK |
|
glucosum monohydricum
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
2.49 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 547.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2022
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 67742
- Drug name
- REKAMBYS, Depot-Injektionssuspension
- Galenic form
- INLFS
- ATC Code
- J05AG05
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 08/10/2021
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- REKAMBYS Depot susp inj 900 mg/3ml flac 3 ml
- Description (DE)
- REKAMBYS Depot Inj Susp 900 mg/3ml Durchstf 3 ml
- Market launch
- 08/10/2021
- Narcotic (BTM)
- No
Other package sizes (1)
None
1 DUR
GTIN: None